David Doherty is a highly experienced bioanalytical scientist with a career spanning over two decades. Currently serving as a Senior Bioanalytical Scientist II at Exelixis since May 2022, Doherty has previously held roles at Nektar Therapeutics from February 2019 to May 2022 as both a Senior Scientist and Scientist II, acting as the Bioanalytical Principal Investigator and analyst in the Pharmacokinetics and Drug Metabolism department. Prior to this, Doherty spent nearly 15 years at Amgen as a Scientist. Doherty earned a Bachelor's Degree in Microbiology and Immunology from California Polytechnic State University-San Luis Obispo in 2000.
This person is not in any teams
This person is not in any offices